Search Results
Update on Princess Margaret Investigator-Initiated Trials | Presented by Dr. Anna Spreafico
Panel | Dr.Lillian Siu, Dr.Mario Sznol, Dr.Philippe Bedard, Dr.Anna Spreafico & Dr.Derek Clouthier
The Status of PD-L1 Testing and What is Next? | Presented by Dr. Ming Tsao
Immune Checkpoint Inhibitors & Co-Stimulatory Molecules | Presented by Dr. Philippe Bedard
#BenchToBedside: Investigator Initiated Clinical Trials
T Cell Engager Antibodies – focus on Hematological Malignancies | Presented by Dr. John Kuruvilla
Oncolytic Viruses | Presented by Dr. Guy Ungerechts
Panel Discussion | Dr. Marcus Butler, Dr. Naoto Hirano, Dr. John Kuruvilla and Dr. Guy Ungerechts
Introduction & Keynote - Harnessing the Immune System to Treat Cancer | Presented by Dr. Mario Sznol
Immuno-oncology: Cold to Hot Tumours
Engineering T Cells in Cancer Therapy: CAR-T, TCR-T and Others | Presented by Dr. Naoto Hirano
The Changing Nature of Phase I Trials